GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway

Journal of Immunology

Volumn 183, Issue 5, 2009, Pages 3390-3399

  Lee, Myeung Su ^a   Kim, Hun Soo ^a   Yeon, Jeong Tae ^a   Choi, Sik Won ^a   Chun, Churl Hong ^a   Kwak, Han Bok ^a   Oh, Jaemin ^a  

^a Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACTIN; CYCLOSPORIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR ALPHA; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; RAS PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; DC STAMP PROTEIN, MOUSE; DC-STAMP PROTEIN, MOUSE; GROWTH INHIBITOR; NERVE PROTEIN; NFATC1 PROTEIN, MOUSE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL FUSION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; MONONUCLEAR CELL; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; RETROVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PHYSIOLOGY; STEM CELL; VIROLOGY;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH INHIBITORS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RAS PROTEINS; RETROVIRIDAE; STEM CELLS;

EID: 70349245002     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804314     Document Type: Article

References (39)

1. Rodan, G. A., and T. J. Martin. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
2. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
3. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
4. Lee, S. H., J. Rho, D. Jeong, J. Y. Sul, T. Kim, N. Kim, J. S. Kang, T. Miyamoto, T. Suda, S. K. Lee, et al. 2006. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12: 1403-1409.
5. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209. (Pubitemid 34461264)
6. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357. (Pubitemid 30649812)
7. Takayanagi, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304.
8. Shinohara, M., T. Koga, K. Okamoto, S. Sakaguchi, K. Arai, H. Yasuda, T. Takai, T. Kodama, T. Morio, R. S. Geha, et al. 2008. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132: 794-806.
9. Ishii, M., K. Iwai, M. Koike, S. Ohshima, E. Kudo-Tanaka, T. Ishii, T. Mima, Y. Katada, K. Miyatake, Y. Uchiyama, and Y. Saeki. 2006. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J. Bone Miner. Res. 21: 965-976.
10. Mbalaviele, G., H. Chen, B. F. Boyce, G. R. Mundy, and T. Yoneda. 1995. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest. 95: 2757-2765.
11. Abe, E., H. Mocharla, T. Yamate, Y. Taguchi, and S. C. Manolagas. 1999. Meltrin-α, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif. Tissue Int. 64: 508-515.
12. Yagi, M., T. Miyamoto, Y. Sawatani, K. Iwamoto, N. Hosogane, N. Fujita, K. Morita, K. Ninomiya, T. Suzuki, K. Miyamoto, et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351.
13. Kim, K., S. H. Lee, J. H. Kim, Y. Choi, and N. Kim. 2008. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22: 176-185.
14. Hartgers, F. C., J. L. Vissers, M. W. Looman, C. van Zoelen, C. Huffine, C. G. Figdor, and G. J. Adema. 2000. DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur. J. Immunol. 30: 3585-3590.
15. Kong, Y. Y., U. Feige, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
16. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
17. Udagawa, N. 2003. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis. J. Bone Miner. Metab. 21: 337-343.
18. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
19. Park, B. K., H. Zhang, Q. Zeng, J. Dai, E. T. Keller, T. Giordano, K. Gu, V. Shah, L. Pei, R. J. Zarbo, et al. 2007. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13: 62-69.
20. Miyazaki, T., H. Katagiri, Y. Kanegae, H. Takayanagi, Y. Sawada, A. Yamamoto, M. P. Pando, T. Asano, I. M. Verma, H. Oda, et al. 2000. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J. Cell Biol. 148: 333-342.
21. Yogesha, S. D., S. M. Khapli, and M. R. Wani. 2005. Interleukin-3 and granulocyte-macrophage colony-stimulating factor inhibits tumor necrosis factor (TNF)-α-induced osteoclast differentiation by down-regulation of expression of TNF receptors 1 and 2. J. Biol. Chem. 280: 11759-11769.
22. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544.
23. Cebon, J., J. E. Layton, D. Maher, and G. Morstyn. 1994. Endogenous haemopoietic growth factors in neutropenia and infection. Br. J. Haematol. 86: 265-274. (Pubitemid 24198987)
24. 2. J. Clin. Invest. 77: 1857-1863.
25. Hamilton, J. A. 2002. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23: 403-408.
26. Cook, A. D., E. L. Braine, I. K. Campbell, M. J. Rich, and J. A. Hamilton. 2001. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3: 293-298.
27. Campbell, I. K., M. J. Rich, R. J. Bischof, A. R. Dunn, D. Grail, and J. A. Hamilton. 1998. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161: 3639-3644.
28. Xu, W. D., G. S. Firestein, R. Taetle, K. Kaushansky, and N. J. Zvaifler. 1989. Cytokines in chronic inflammatory arthritis, II: Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J. Clin. Invest. 83: 876-882.
29. Asagiri, M., K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, E. F. Wagner, T. W. Mak, E. Serfling, and H. Takayanagi. 2005. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269.
30. Rajotte, D., H. B. Sadowski, A. Haman, K. Gopalbhai, S. Meloche, L. Liu, G. krystal, and T. Hoang. 1996. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor. Blood 88: 2906-2916.
31. Janknecht, R., W. H. Ernst, V. Pingoud, and A. Nordheim. 1993. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12: 5097-5104. (Pubitemid 23358499)
32. Joo, A., H. Aburatani, E. Morii, H. Iba, and A. Yoshimura. 2004. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression. Oncogene 23: 726-734.
33. O'Donnell, A., S. H. Yang, and A. D. Sharrocks. 2008. MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch. Mol. Cell 29: 780-785.
34. Weisz, A., and R. Rosales. 1990. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 18: 5097-5106.
35. Murphy, L. O., and J. Blenis. 2006. MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31: 268-275.
36. Kolch, W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6: 827-837.
37. 3 induction during receptor activator of nuclear factor κB ligand (RANKL)-directed osteoclast differentiation. Exp. Cell Res. 289: 368-377.
38. 3 integrin in osteoclast migration and formation of the sealing zone. J. Cell Sci. 112: 3985-3993.
39. 3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105: 433-440.